HYPERA (HYPE3) Main Indicators
Basic Data - HYPE3
| Company | HYPERA |
| Corporate Name | HYPERA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Fabricacão de Medicamentos Alopáticos para uso humano |
| Share | HYPE3 |
| Quote Date | 04/03/2025 |
| Share Type | ON |
| Last Closing | R$ 20.55 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 59.49 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IBOVESPA, IBRA, IBRX, IBRX50, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, SMLL |
| Updated 04/04/2025 | |
Relative Prices - HYPE3
| Price/Earnings | 9.71 |
| Price/SBV | 1.08 |
| Price/Net Sales | 1.75 |
| Price/CFO | 5.13 |
| Price/FCF | 6.17 |
| Price/Total Assets | 0.53 |
| Price/EBIT | 7.15 |
| Price/Working Capital | 4.75 |
| Price/NCAV | -1.34 |
| EV/EBIT | 11.35 |
| EV/EBITDA | 9.83 |
| EV/Net Sales | 2.78 |
| EV/CFO | 8.13 |
| EV/FCF | 9.79 |
| EV/Total Assets | 0.84 |
| Company Market Cap | R$ 13.02 B |
| Enterprise Value | R$ 20.66 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 20.55 |
| Share Price Date | 04/03/2025 |
| Dividend Yield | 5.69% |
| Updated 04/04/2025 | |
Income Statement - HYPE3
| Net Revenue | R$ 7.44 B |
| Gross Result | R$ 4.38 B |
| EBIT | R$ 1.82 B |
| Depreciation and Amortization | - R$ 281.06 M |
| EBITDA | R$ 2.10 B |
| Net Profit | R$ 1.34 B |
| Net Profit/Share | R$ 2.12 |
| Updated 03/20/2025 | |
| Net Revenue | R$ 1.51 B |
| Gross Result | R$ 786.44 M |
| EBIT | R$ 62.04 M |
| Depreciation and Amortization | - R$ 74.87 M |
| EBITDA | R$ 136.91 M |
| Net Profit | R$ 79.56 M |
| Profit/Share | R$ 0.13 |
| Updated 03/20/2025 | |
Price and Volume Behavior - HYPE3
| Lowest Price 52 weeks | R$ 16.29 |
| Highest Price 52 weeks | R$ 31.06 |
| Variation 2025 | 16.99% |
| Variation 1 year | -31.44% |
| Variation 2 years(total) | -38.60% |
| Variation 2 years(yearly) | -21.62% |
| Variation 3 years(total) | -41.29% |
| Variation 3 years(yearly) | -16.23% |
| Variation 4 years(total) | -24.86% |
| Variation 4 years(yearly) | -6.88% |
| Variation 5 years(total) | -13.73% |
| Variation 5 years(yearly) | -2.91% |
| Average Daily Volume (3 months) | R$ 99.81 M |
| Updated 04/04/2025 | |
Returns and Margins - HYPE3
| Return on Initial Tangible Capital | 15.07% |
| Return on Initial Invested Capital | 6.37% |
| Pre-Tax Return on Initial Tangible Capital | 22.83% |
| Pre-Tax Return on Initial Invested Capital | 9.65% |
| Return on Initial Shareholder´s Equity | 11.66% |
| Return on Initial Asset | 5.47% |
| Gross Margin | 58.86% |
| Net Margin | 18.02% |
| EBIT Margin | 24.45% |
| EBITDA Margin | 28.23% |
| Initial Asset Turnover | 0.30 |
| Financial Leverage | 2.03 |
| Liabilities/Net Worth | 1.03 |
| Net Debt/EBITDA | 3.64 |
| Updated 03/20/2025 | |
Balance Sheet - HYPE3
| Cash and Cash Equivalents | R$ 1.74 B |
| Total Assets | R$ 24.56 B |
| Short-Term Debt | R$ 1.39 B |
| Long-Term Debt | R$ 7.99 B |
| Gross Debt | R$ 9.38 B |
| Net Debt | R$ 7.64 B |
| Shareholder´s Equity | R$ 12.10 B |
| Share Book Value | R$ 19.10 |
| Common Shares | 633,420,823 |
| Preferred Shares | 0 |
| Total | 633,420,823 |
| Common Shares in Treasury | 723,554 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 723,554 |
| Common Shares (Except Treasury) | 632,697,269 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 632,697,269 |
| Updated 03/20/2025 | |
Cash Flow - HYPE3
| Operating Cash Flow | R$ 2.54 B |
| Cash Flow from Investments | - R$ 592.44 M |
| Financing Cash Flow | - R$ 2.79 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 841.57 M |
| Updated 03/20/2025 | |
| Operating Cash Flow | R$ 698.20 M |
| Cash Flow from Investments | - R$ 227.63 M |
| Financing Cash Flow | - R$ 1.94 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 1.47 B |
| Updated 03/20/2025 | |
Experimental - HYPE3
| CAPEX 3 months | - R$ 160.24 M |
| Free Cash Flow 3 months | R$ 537.96 M |
| CAPEX 12 months | - R$ 429.39 M |
| Free Cash Flow 12 months | R$ 2.11 B |
| Updated 03/20/2025 | |